|
|
.
NPI Detail
NPI: 1346213469
Type: Organization
Taxonomy Code: 273Y00000X
Hospital-Rehabilitation Unit
Hospital Units/Rehabilitation Unit
255 XXXXXXXXX XXX
SUFFERN, NY 109014846
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1346213469*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXX
|
$XXXX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXX
|
$XXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXX
|
$XXXXX.X
|
| 85610
|
PROTHROMBIN TIME
|
XXXX
|
$XXX.XX
|
| 80048
|
METABOLIC PANEL TOTAL CA
|
XXXX
|
$XXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXX
|
-
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J0583
|
Bivalirudin
|
XXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXX
|
$XXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J3111
|
Inj. romosozumab-aqqg 1 mg
|
XXXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXX
|
-
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXX
|
$XXXXX.XX
|
| J7168
|
Prothrombin complex kcentra
|
XXXX
|
$XXXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXX
|
$XXXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXX
|
-
|
| J2182
|
Injection, mepolizumab, 1mg
|
XXXX
|
$XXXXXX.XX
|
| J9358
|
Inj fam-trastu deru-nxki 1mg
|
XXXX
|
$XXXXXX.XX
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXX
|
$XXXXXX.XX
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXX
|
-
|
| J2795
|
Ropivacaine hcl injection
|
XXXX
|
-
|
| J2405
|
Ondansetron hcl injection
|
XXXX
|
-
|
| J9264
|
Paclitaxel protein bound
|
XXXX
|
$XXXXX.XX
|
| J2323
|
Natalizumab injection
|
XXXX
|
$XXXXX.XX
|
| J1930
|
Lanreotide injection
|
XXXX
|
$XXXXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXX
|
$XXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXX
|
-
|
| J0222
|
Inj., patisiran, 0.1 mg
|
XXXX
|
$XXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXX
|
$XXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXX
|
$XXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| U0003
|
Cov-19 amp prb hgh thruput
|
XXXX
|
$XXXXXX.XX
|
| U0005
|
Infec agen detec ampli probe
|
XXXX
|
$XXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
